Calcionics Corporation

14787 NE 95th Street, Suite A

Redmond, WA 98052

 

Tel: (206) 793-0867

 

Info:  email chip@calcionics.com

 

 

 

∙ Calcification of soft tissues, in particular the hardening of the arteries, is associated with cardiovascular disease, renal disease, diabetes, and the aging process.

∙ Calcification correlates with disease severity and clinical events and increases the risk of stroke, ischemia, myocardial infarction, and heart valve failure.

∙ Calcification of medical devices and prosthetics results in decreased functionality and potentiates failure of the implant.

Calcionics develops first-in-class peptide therapeutics targeting calcification to prevent and treat cardiovascular disease and other medical conditions.